BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36357014)

  • 21. Sex-related differences in outcome after left atrial appendage occlusion: Insights from Europe and the EWOLUTION registry.
    Paitazoglou C; Eitel I; Stiermaier T; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Vireca E; Wohlmuth P; Lucas B; Bergmann MW;
    Catheter Cardiovasc Interv; 2023 Aug; 102(2):283-292. PubMed ID: 37393575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Watchman device migration and embolization: A report from the NCDR LAAO Registry.
    Friedman DJ; Freeman JV; Zimmerman S; Tan Z; Pereira L; Faridi KF; Curtis JP
    J Cardiovasc Electrophysiol; 2023 May; 34(5):1192-1195. PubMed ID: 37078339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Outcomes at 1 Year Following Transcatheter Left Atrial Appendage Occlusion in the United States.
    Price MJ; Slotwiner D; Du C; Freeman JV; Turi Z; Rammohan C; Kusumoto FM; Kavinsky C; Akar J; Varosy PD; Koutras C; Curtis JP; Masoudi FA
    JACC Cardiovasc Interv; 2022 Apr; 15(7):741-750. PubMed ID: 35393108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion.
    Simard T; Jung RG; Lehenbauer K; Piayda K; Pracoń R; Jackson GG; Flores-Umanzor E; Faroux L; Korsholm K; Chun JKR; Chen S; Maarse M; Montrella K; Chaker Z; Spoon JN; Pastormerlo LE; Meincke F; Sawant AC; Moldovan CM; Qintar M; Aktas MK; Branca L; Radinovic A; Ram P; El-Zein RS; Flautt T; Ding WY; Sayegh B; Benito-González T; Lee OH; Badejoko SO; Paitazoglou C; Karim N; Zaghloul AM; Agrawal H; Kaplan RM; Alli O; Ahmed A; Suradi HS; Knight BP; Alla VM; Panaich SS; Wong T; Bergmann MW; Chothia R; Kim JS; Pérez de Prado A; Bazaz R; Gupta D; Valderrabano M; Sanchez CE; El Chami MF; Mazzone P; Adamo M; Ling F; Wang DD; O'Neill W; Wojakowski W; Pershad A; Berti S; Spoon D; Kawsara A; Jabbour G; Boersma LVA; Schmidt B; Nielsen-Kudsk JE; Rodés-Cabau J; Freixa X; Ellis CR; Fauchier L; Demkow M; Sievert H; Main ML; Hibbert B; Holmes DR; Alkhouli M
    J Am Coll Cardiol; 2021 Jul; 78(4):297-313. PubMed ID: 34294267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pericardial effusion requiring intervention in patients undergoing percutaneous left atrial appendage occlusion: Prevalence, predictors, and associated in-hospital adverse events from 17,700 procedures in the United States.
    Munir MB; Khan MZ; Darden D; Pasupula DK; Balla S; Han FT; Reeves R; Hsu JC
    Heart Rhythm; 2021 Sep; 18(9):1508-1515. PubMed ID: 34020049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracardiac echocardiography- versus transesophageal echocardiography-guided left atrial appendage occlusion with Watchman FLX.
    Gianni C; Horton RP; Della Rocca DG; Mohanty S; Al-Ahmad A; Bassiouny MA; Burkhardt JD; Gallinghouse GJ; Hranitzky PM; Sanchez JE; Natale A
    J Cardiovasc Electrophysiol; 2021 Oct; 32(10):2781-2784. PubMed ID: 34411376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation.
    Kar S; Doshi SK; Alkhouli M; Camm AJ; Coylewright M; Gibson MC; Granger CB; Gurol ME; Huber K; Mansour M; Nair DG; Natale A; Pocock SJ; Reddy VR; Saliba W; Christen T; Allocco DJ; Ellenbogen KA; Leon MB
    Am Heart J; 2023 Oct; 264():123-132. PubMed ID: 37279840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left atrial appendage closure in patients with prohibitive anatomy: Insights from PINNACLE FLX.
    Ellis CR; Jackson GG; Kanagasundram AN; Mansour M; Sutton B; Houle VM; Kar S; Doshi S; Osorio J
    Heart Rhythm; 2021 Jul; 18(7):1153-1161. PubMed ID: 33957090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Watchman FLX Device: First European Experience and Feasibility of Intracardiac Echocardiography to Guide Implantation.
    Korsholm K; Samaras A; Andersen A; Jensen JM; Nielsen-Kudsk JE
    JACC Clin Electrophysiol; 2020 Dec; 6(13):1633-1642. PubMed ID: 33334441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of operatoŕs experience on
    Cruz-González I; Torres Saura F; Trejo-Velasco B; Antonio Fernández Díaz J; Fajardo Molina R; Del Valle-Fernández R; Moreno Terribas G; Martí Sánchez D; López-Mínguez JR; Gomez-Blazquez I; Sanmartin Pena JC; Botas J; Martin Lorenzo P; Palazuelos J; Albarrán Rincon R; Mohandes M; Rodriguez Entem FJ; Martí G; Valero E; Gutiérrez H; Amat-Santos IJ; Nombela-Franco L; Salinas P; Teruel L; Gomez-Hospital JA; Arzamendi D; Torres Sanabria M; Calle Pérez G; Cañadas Pruaño D; Pérez de Prado A; Benito González T; Arroyo-Úcar E; Estévez-Loureiro R; Caneiro-Queija B; Ibañez Criado JL; Ruiz-Nodar JM
    Int J Cardiol Heart Vasc; 2022 Feb; 38():100941. PubMed ID: 35024431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
    Holmes DR; Kar S; Price MJ; Whisenant B; Sievert H; Doshi SK; Huber K; Reddy VY
    J Am Coll Cardiol; 2014 Jul; 64(1):1-12. PubMed ID: 24998121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex Differences in Procedural Outcomes Among Patients Undergoing Left Atrial Appendage Occlusion: Insights From the NCDR LAAO Registry.
    Darden D; Duong T; Du C; Munir MB; Han FT; Reeves R; Saw J; Zeitler EP; Al-Khatib SM; Russo AM; Minges KE; Curtis JP; Freeman JV; Hsu JC
    JAMA Cardiol; 2021 Nov; 6(11):1275-1284. PubMed ID: 34379072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed Pericardial Effusion Following Left Atrial Appendage Closure: A 5-Year Single-Center Experience.
    Mogalapalli A; Kumar S; Lobo T; Reed J; Dallan LAP; Yoon SH; Filby SJ
    J Invasive Cardiol; 2023 Jan; 35(1):E1-E6. PubMed ID: 36446576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Left atrial appendage sealing performance of the Amplatzer Amulet and Watchman FLX device.
    Korsholm K; Kramer A; Andersen A; Saw J; Nørgaard BL; Jensen JM; Nielsen-Kudsk JE
    J Interv Card Electrophysiol; 2023 Mar; 66(2):391-401. PubMed ID: 35951214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Watchman FLX vs. Watchman 2.5 in a Dual-Center Left Atrial Appendage Closure Cohort: the WATCH-DUAL study.
    Galea R; Mahmoudi K; Gräni C; Elhadad S; Huber AT; Heg D; Siontis GCM; Brugger N; Sebag F; Windecker S; Valgimigli M; Landolff Q; Roten L; Amabile N; Räber L
    Europace; 2022 Oct; 24(9):1441-1450. PubMed ID: 35253840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of the new generation Watchman FLX device compared to the Watchman 2.5: a systematic review and meta-analysis.
    Najim M; Reda Mostafa M; Eid MM; Alabdouh A; Awad AK; Elbanna M; Mohamed S; Alweis R; Al-Azizi KM; Mamas MA
    Am J Cardiovasc Dis; 2023; 13(5):291-299. PubMed ID: 38026111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left atrial appendage occlusion with the Amplatzer Cardiac Plug could improve survival and prevent thrombo-embolic and major bleeding events in atrial fibrillation patients with increased bleeding risk.
    Budts W; Laenens D; Van Calenbergh F; Vermeersch P; De Potter T; Aminian A; Benit E; Stammen F; Kefer J
    Acta Cardiol; 2016 Apr; 71(2):135-43. PubMed ID: 27090034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial.
    Korsholm K; Damgaard D; Valentin JB; Packer EJS; Odenstedt J; Sinisalo J; Putaala J; Næss H; Al-Jazi MA; Karlsson JE; Pontoppidan J; Modrau B; Hjort J; Matzen KL; Johnsen SP; Nielsen-Kudsk JE
    Am Heart J; 2022 Jan; 243():28-38. PubMed ID: 34537184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.